Cargando…

Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota

Trimethylamine N-oxide (TMAO) leads to the development of cardiovascular and chronic kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity of TMAO. In this study, high-fat diet-fed ApoE-/- mice were treated with finasteride, ranitidine, and andrioe. Subsequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Junfeng, Lai, Lingyun, Lin, Jiajia, Zheng, Jiajia, Nie, Xiaoli, Zhu, Xiaoye, Xue, Jun, Liu, Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019130/
https://www.ncbi.nlm.nih.gov/pubmed/32071549
http://dx.doi.org/10.7150/ijbs.40934
_version_ 1783497455664365568
author Liu, Junfeng
Lai, Lingyun
Lin, Jiajia
Zheng, Jiajia
Nie, Xiaoli
Zhu, Xiaoye
Xue, Jun
Liu, Te
author_facet Liu, Junfeng
Lai, Lingyun
Lin, Jiajia
Zheng, Jiajia
Nie, Xiaoli
Zhu, Xiaoye
Xue, Jun
Liu, Te
author_sort Liu, Junfeng
collection PubMed
description Trimethylamine N-oxide (TMAO) leads to the development of cardiovascular and chronic kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity of TMAO. In this study, high-fat diet-fed ApoE-/- mice were treated with finasteride, ranitidine, and andrioe. Subsequently, the distribution and quantity of gut microbiota in the faeces of the mice in each group were analysed using 16S rRNA sequencing of the V3+V4 regions. Pathological examination confirmed that both ranitidine and finasteride reduced atherosclerosis and renal damage in mice. HPLC analysis also indicated that ranitidine and finasteride significantly reduced the synthesis of TMAO and the TMAO precursor delta-Valerobetaine in their livers. The 16S rRNA sequencing showed that all 3 drugs significantly increased the richness and diversity of gut microbiota in the model mice. Bioinformatic analysis revealed that the faeces of mice treated with ranitidine and finasteride, had significant increases in the number of microbes in the families g_Helicobacter, f_Desulfovibrionaceae, Mucispirillum_schaedleri_ASF457, and g_Blautia, whereas the relative abundances of microbes in the families Enterobacter_sp._IPC1-8 and g_Bacteroides were significantly reduced. The microbiota metabolic pathways, such as nucleotide and cofactor and vitamin metabolism were also significantly increased, whereas the activities of metabolic signalling pathways related to glycan biosynthesis and metabolism and cardiovascular diseases were significantly reduced. Therefore, our study indicates that in addition to their known pharmacological effects, ranitidine and finasteride also exhibit potential cardiovascular and renal protective effects. They inhibit the synthesis and metabolism of TMAO and delay the deposition of lipids and endotoxins through improving the composition of the gut microbiota.
format Online
Article
Text
id pubmed-7019130
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-70191302020-02-18 Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota Liu, Junfeng Lai, Lingyun Lin, Jiajia Zheng, Jiajia Nie, Xiaoli Zhu, Xiaoye Xue, Jun Liu, Te Int J Biol Sci Research Paper Trimethylamine N-oxide (TMAO) leads to the development of cardiovascular and chronic kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity of TMAO. In this study, high-fat diet-fed ApoE-/- mice were treated with finasteride, ranitidine, and andrioe. Subsequently, the distribution and quantity of gut microbiota in the faeces of the mice in each group were analysed using 16S rRNA sequencing of the V3+V4 regions. Pathological examination confirmed that both ranitidine and finasteride reduced atherosclerosis and renal damage in mice. HPLC analysis also indicated that ranitidine and finasteride significantly reduced the synthesis of TMAO and the TMAO precursor delta-Valerobetaine in their livers. The 16S rRNA sequencing showed that all 3 drugs significantly increased the richness and diversity of gut microbiota in the model mice. Bioinformatic analysis revealed that the faeces of mice treated with ranitidine and finasteride, had significant increases in the number of microbes in the families g_Helicobacter, f_Desulfovibrionaceae, Mucispirillum_schaedleri_ASF457, and g_Blautia, whereas the relative abundances of microbes in the families Enterobacter_sp._IPC1-8 and g_Bacteroides were significantly reduced. The microbiota metabolic pathways, such as nucleotide and cofactor and vitamin metabolism were also significantly increased, whereas the activities of metabolic signalling pathways related to glycan biosynthesis and metabolism and cardiovascular diseases were significantly reduced. Therefore, our study indicates that in addition to their known pharmacological effects, ranitidine and finasteride also exhibit potential cardiovascular and renal protective effects. They inhibit the synthesis and metabolism of TMAO and delay the deposition of lipids and endotoxins through improving the composition of the gut microbiota. Ivyspring International Publisher 2020-01-14 /pmc/articles/PMC7019130/ /pubmed/32071549 http://dx.doi.org/10.7150/ijbs.40934 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Liu, Junfeng
Lai, Lingyun
Lin, Jiajia
Zheng, Jiajia
Nie, Xiaoli
Zhu, Xiaoye
Xue, Jun
Liu, Te
Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
title Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
title_full Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
title_fullStr Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
title_full_unstemmed Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
title_short Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
title_sort ranitidine and finasteride inhibit the synthesis and release of trimethylamine n-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019130/
https://www.ncbi.nlm.nih.gov/pubmed/32071549
http://dx.doi.org/10.7150/ijbs.40934
work_keys_str_mv AT liujunfeng ranitidineandfinasterideinhibitthesynthesisandreleaseoftrimethylaminenoxideandmitigatesitscardiovascularandrenaldamagethroughmodulatinggutmicrobiota
AT lailingyun ranitidineandfinasterideinhibitthesynthesisandreleaseoftrimethylaminenoxideandmitigatesitscardiovascularandrenaldamagethroughmodulatinggutmicrobiota
AT linjiajia ranitidineandfinasterideinhibitthesynthesisandreleaseoftrimethylaminenoxideandmitigatesitscardiovascularandrenaldamagethroughmodulatinggutmicrobiota
AT zhengjiajia ranitidineandfinasterideinhibitthesynthesisandreleaseoftrimethylaminenoxideandmitigatesitscardiovascularandrenaldamagethroughmodulatinggutmicrobiota
AT niexiaoli ranitidineandfinasterideinhibitthesynthesisandreleaseoftrimethylaminenoxideandmitigatesitscardiovascularandrenaldamagethroughmodulatinggutmicrobiota
AT zhuxiaoye ranitidineandfinasterideinhibitthesynthesisandreleaseoftrimethylaminenoxideandmitigatesitscardiovascularandrenaldamagethroughmodulatinggutmicrobiota
AT xuejun ranitidineandfinasterideinhibitthesynthesisandreleaseoftrimethylaminenoxideandmitigatesitscardiovascularandrenaldamagethroughmodulatinggutmicrobiota
AT liute ranitidineandfinasterideinhibitthesynthesisandreleaseoftrimethylaminenoxideandmitigatesitscardiovascularandrenaldamagethroughmodulatinggutmicrobiota